Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

NCT00261820 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft Rejection
Kidney Failure
Kidney Transplantation

Interventions

DRUG: tacrolimus
DRUG: mycophenolate mofetil
DRUG: methylprednisolone
DRUG: prednisolone
DRUG: sirolimus

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer